Drug Cos. Not Ready for 'Deep End' of Remote Trials

By Kaitlin Gebby · February 1, 2024, 7:47 PM EST

Enthusiasm among drug companies and federal officials about increasing diversity among clinical subjects through "decentralized" trials is being tempered by unknowns about the regulatory landscape, a group of experts said Thursday....

To view the full article, register now.